We are live on ! Find out more
NA

NewEdge Advisors Portfolio holdings

AUM $27.7B
1-Year Est. Return 22.98%
This Fund
S&P 500
This Quarter Est. Return
+6.1%
1 Year Est. Return
+22.98%
3 Year Est. Return
+69.07%
5 Year Est. Return
+86.55%
10 Year Est. Return
+264.51%
AUM
$8.85B
AUM Growth
+$851M
Cap. Flow
+$412M
Cap. Flow %
4.65%
Top 10 Hldgs %
16.84%
Holding
3,702
New
289
Increased
1,323
Reduced
1,138
Closed
218

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$30.8M
2
UL icon
Unilever
UL
+$28.5M
3
CMCSA icon
Comcast
CMCSA
+$27.6M
4
ITW icon
Illinois Tool Works
ITW
+$27.1M
5
MDLZ icon
Mondelez International
MDLZ
+$26.8M

Top Sells

Rank Stock Value
1
ACN icon
Accenture
ACN
+$30.6M
2
ABT icon
Abbott
ABT
+$28.3M
3
BMY icon
Bristol-Myers Squibb
BMY
+$27.8M
4
DOV icon
Dover
DOV
+$27.1M
5
ULST icon
State Street Ultra Short Term Bond ETF
ULST
+$24.4M

Sector Composition

Rank Sector Weight
1 Technology 12.26%
2 Financials 5.78%
3 Healthcare 5.7%
4 Consumer Discretionary 4.46%
5 Industrials 3.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NMRD
3351
DELISTED
Nemaura Medical, Inc. Common Stock
NMRD
$333 ﹤0.01%
360
DNOW icon
3352
DNOW Inc
DNOW
$2.51B
$332 ﹤0.01%
32
+10
+45% +$100
PRQR icon
3353
ProQR Therapeutics
PRQR
$251M
$324 ﹤0.01%
200
AVEM icon
3354
Avantis Emerging Markets Equity ETF
AVEM
$25.4B
$323 ﹤0.01%
6
-546
-99% -$29K
PGJ icon
3355
Invesco Golden Dragon China ETF
PGJ
$97.3M
$323 ﹤0.01%
12
AVA icon
3356
Avista
AVA
$3.39B
$314 ﹤0.01%
+8
New +$339
TGI
3357
DELISTED
Triumph Group
TGI
$309 ﹤0.01%
25
FORM icon
3358
FormFactor
FORM
$8.21B
$308 ﹤0.01%
9
-10,602
-100% -$317K
AVID
3359
DELISTED
Avid Technology Inc
AVID
$306 ﹤0.01%
12
TMQ
3360
Trilogy Metals
TMQ
$549M
$297 ﹤0.01%
500
-16
-3% -$9
FATH
3361
DELISTED
Fathom Digital Manufacturing Corporation
FATH
$296 ﹤0.01%
37
CALC icon
3362
CalciMedica
CALC
$13.3M
$285 ﹤0.01%
+71
New +$310
EVBG
3363
DELISTED
Everbridge, Inc. Common Stock
EVBG
$269 ﹤0.01%
+10
New +$270
ACCO icon
3364
Acco Brands
ACCO
$390M
$266 ﹤0.01%
51
CVGW
3365
DELISTED
Calavo Growers
CVGW
$261 ﹤0.01%
+9
New +$279
CWT icon
3366
California Water Service
CWT
$3.02B
$258 ﹤0.01%
+5
New +$281
VCYT icon
3367
Veracyte
VCYT
$4.77B
$255 ﹤0.01%
10
-2,099
-100% -$50.9K
BPMC
3368
DELISTED
Blueprint Medicines
BPMC
$253 ﹤0.01%
4
TK icon
3369
Teekay
TK
$983M
$248 ﹤0.01%
41
LKFT
3370
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.81B
$244 ﹤0.01%
6
TALO icon
3371
Talos Energy
TALO
$2.44B
$236 ﹤0.01%
17
VST icon
3372
Vistra
VST
$50.1B
$236 ﹤0.01%
9
BFLY icon
3373
Butterfly Network
BFLY
$2.14B
$230 ﹤0.01%
+100
New +$223
SFIX
3374
Stitch Fix
SFIX
$547M
$228 ﹤0.01%
59
OUST icon
3375
Ouster
OUST
$2.39B
$223 ﹤0.01%
45
+1
+2% +$5

Similar funds

NewEdge Advisors's Q2 2023 Portfolio in Review

As of Q2 2023, NewEdge Advisors held 3,702 positions worth $8.85B, up 11% from $8B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

NewEdge Advisors deployed $412M of net new capital in Q2 2023, opening 289 new positions and adding to 1,323 existing holdings. Its largest new stake was Franklin International Core Dividend Tilt Index ETF: 317,686 shares worth $9.29M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Accenture, an estimated $30.6M trimmed.

  • NewEdge Advisors's largest Q2 2023 buy was Franklin International Core Dividend Tilt Index ETF: 317,686 shares worth $9.29M.
  • NewEdge Advisors added most to AbbVie in Q2 2023, an estimated $30.8M increase.
  • NewEdge Advisors's biggest Q2 2023 reduction was Accenture, cutting an estimated $30.6M.
  • NewEdge Advisors fully exited Quadratic Deflation ETF in Q2 2023, selling an estimated $3.13M.
  • NewEdge Advisors's ten largest holdings make up 17% of its $8.85B portfolio in Q2 2023.
  • NewEdge Advisors opened 289 new positions and closed 218 in Q2 2023.
  • NewEdge Advisors's portfolio value rose 11% quarter-over-quarter to $8.85B.

Based on NewEdge Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.